Presentation is loading. Please wait.

Presentation is loading. Please wait.

Karyn P. Leible, RN, MD, CMD Chief Medical Officer Jewish Senior Life of Rochester, NY Immediate Past President, AMDA Quality Assurance and Process Improvement.

Similar presentations

Presentation on theme: "Karyn P. Leible, RN, MD, CMD Chief Medical Officer Jewish Senior Life of Rochester, NY Immediate Past President, AMDA Quality Assurance and Process Improvement."— Presentation transcript:

1 Karyn P. Leible, RN, MD, CMD Chief Medical Officer Jewish Senior Life of Rochester, NY Immediate Past President, AMDA Quality Assurance and Process Improvement

2 Speaker Disclosures: Dr. Leible has disclosed that she has no relevant financial relationships.

3 Learning Objectives: By the end of the session, participants will be able to: 1) discuss the changes in nursing facility Quality Assurance and Assessment (QA&A) as outlined in health care reform legislation 2) discuss tools and processes that are associated with best practices for quality assurance and process improvement 3) discuss the role of the facility medical director in the facility Quality Assurance Process Improvement program

4 Definitions ◦ Quality Assessment- is an evaluation of a process to determine if a defined standard of quality is being achieved. ◦ Quality Assurance- is the organizational structure, processes, and procedures designed to ensure that care practices are consistently applied ◦ Quality Improvement- (Process or Performance Improvement) is an ongoing interdisciplinary process that is designed to improve the delivery of services and resident outcomes.

5 Quality Assurance and Process Improvement The Patient Protection and Affordable Care Act (ACA)  Signed into law March 23, 2010 Many provisions for which CMS is responsible for implementing Survey and Certification Group  Section 6102  Establishment of standards relating to quality assurance and process improvement  Purpose of program is to strengthen current requirements and promote accountability for resident care and safety by nursing facilities

6 Nursing Home QAPI: A Proactive Approach to Improving Quality and Safety Transforming nursing homes through continuous attention to quality of care and quality of life

7 Quality Assurance and Performance Improvement (QAPI) Overview Expands current regulations for QAA Sets expectation for a sound, basic plan for QAPI that will support the systems of care and quality of life in every nursing home A demonstration project is testing QAPI in 17 nursing homes, and preparing for national implementation

8 QAPI Nursing Home Demonstration CMS contracted with University of Minnesota, with Stratis Health serving as a subcontractor, to develop the demo and early implementation strategies CMS will support stakeholders, providers, consumer advocates, consumers, and surveyors through outreach and communication Technical Expert Panel (TEP) is reviewing QAPI program materials

9 QAPI Nursing Home Demonstration Two year demo began September 2011 Four states - Florida- Massachusetts - California - Minnesota Diversity of participating nursing homes Learning Collaborative based on IHI model Tools and resources being developed Extensive evaluation planned

10 Five Elements of QAPI Design & Scope Governance & Leadership Feedback, Data Systems and Monitoring Performance Improvement Projects (PIPs) Systematic Analysis & Systemic Action

11 5 Elements of QAPI Design and Scope  Comprehensive and ongoing plan  Includes all departments and functions  Addresses safety, quality of care, QOL, resident choice, transitions  Based on best available evidence  QAPI plan

12 5 Elements of QAPI Governance and Leadership  Boards/owners and executive leadership  Buy in and support  Training and organizational climate  Administration sees value  Sufficient resources  Sustainability

13 5 Elements of QAPI Feedback, Data monitoring Systems, and Monitoring  Multiple sources, including resident and staff  Benchmarking and targeting  Adverse events

14 5 Elements of QAPI Performance Improvement Projects  Prioritized topics  Number of PIPs depend on the facility program  Team Chartered  PDSA Cycle

15 5 Elements of QAPI Systematic Analysis and Systemic action  Root cause analysis  Systems thinking  Systematic changes as needed

16 AMDA Position Paper The Role of the medical director on the QA committee begins with an awareness of the current program in the facility. (March 2011)  Structure and process of the facility program  Role of the IDT participants  How issues are identified, addressed and monitored

17 Case presentation You are the medical director/ administrator/ director of nursing of a 100 bed facility just outside of Denver. During the facility QAA meeting it is brought to your attention that the facility use of antipsychotics is above the state average based on data just released from the CMS.

18 QAPI The facility provided data through monitoring  a potential problem is identified. Next steps will be to evaluate if a true problem exists  look at root causes, analyze and interpret data and develop interventions.  Monitor and re-evaluate All part of an over all program to proactively monitor facility processes of care in order to ensure the highest quality of care and quality of life

19 QAA Tools Proprietary programs/ Corporate programs  ABAQIS  My InnerView Facility reports  Pressure ulcers  Falls  Accidents  Infection Control QI/QM data  MDS derived MDS 3.0 data

20 MDS 3.0 Opportunities to assess quality through the facility own data collection opportunities with 3.0 Assessments are done for OBRA  Day 14 then quarterly  Annual review  Discharge Assessments are done for PPS  Days 5, 14, 30, 60, 90

21 Quality Measures Short stay  % of residents on a scheduled pain medication regimen on admission who report a decrease in pain intensity or frequency  % of residents who self report moderate to severe pain  % of residents with pressure ulcers that are new or worsened

22 Quality Measures Short stay  % of residents assessed and given, appropriately, the Seasonal Influenza vaccine  % of residents assessed and given, appropriately, the Pneumococcal Vaccine Long stay  % of residents assessed and given, appropriately, the Seasonal Influenza Vaccine  % of residents assessed and given, appropriately, the Pneumococcal Vaccine

23 Quality Measures Long Stay  % of residents experiencing one or more falls with major injury  % of residents who self report moderate to severe pain  % of high risk residents with pressure ulcers  % of long stay residents with a urinary tract infection  % of long stay residents who lose control of bowels and bladder

24 Quality Measures Long Stay  Residents who have/had a catheter inserted and left in their bladder  % of residents who were physically restrained  % of residents who needed help with physical activities has increased  % of long stay residents who lose to much weight  % of residents who have depressive symptoms

25 Quality Measures- Antipsychotics June 2012 Public Reporting Short Stay Measure  Incidence of short stay residents that are given an antipsychotic medication after admission to the nursing home

26 Quality Measures- Antipsychotics Long Stay Measure  Percentage of long stay residents receiving an antipsychotic who do not have a diagnosis of Tourette’s, Huntington's or Schizophrenia  Diagnosis of hallucinations, delusions or bipolar are no longer excluded Reporting currently last quarters of 2011 and first 2 of 2012

27 Quality Measures-Antipsychotics National average 23.9% (long stay) goal for 15% reduction would bring the national prevalence rate to 20.3%

28 MDS 3.0- Section N Medications N0400. Medications Received. Check all medications the resident received at any time during the last 7 days or since admission/reentry if less than 7 days. Antipsychotic. Antianxiety. Antidepressant. Hypnotic. Anticoagulant (warfarin, heparin, or low-molecular weight heparin). Antibiotic. Diuretic. Z. None of the above were received.

29 MDS 3.0- Section I In the past 7 days: Check all that apply Anxiety Disorder Depression (other than bipolar) Manic Depression (bipolar) Psychotic Disorder (other than Schizophrenia) Schizophrenia (schizoaffective, schizophreniform disorders) Post traumatic stress disorder

30 MDS 3.0 Potential areas for quality monitoring  BIMS scores  PHQ-9 scores  Pain management  Late loss ADL (toileting, eating, transfers, bed mobility)  Urinary incontinence  Weight loss  Prognosis (less than 6 months)  Pressure ulcers

31 Quality Assurance and Assessment Facility Reports  Pressure ulcers  Infection control  Falls  Antipsychotic use

32 Incidence Number of new whatevers Average census x time Average census x time = bed days of care Assume stable census of 100 elder in month of September then BDOC= 3000 Multiply incidence by 1000 to get # per 1000 resident days

33 Incidence In September Shady Pines had 5 facility acquired urinary tract infections. They had a stable census of 100 residents. What is the incidence of facility acquired urinary tract infections?

34 Incidence 5_UTI X 1000 = 1.7 3000 (BDOC) BDOC = 100 resident x 30 days

35 Prevalence Prevalence is defined as the total number of cases of the disease in the population at a given time, or total number of cases in the population Number of whatevers that exist number at risk

36 Prevalence Shady Pines has 4 residents with pressure ulcers. Non of the ulcers are new. What is the prevalence of pressure ulcers in the facility?

37 Prevalence 4 elders with pressure ulcers X 100 100 elders at risk.04 X 100 = 4 % Consider unit of measure number of ulcers versus number of elders with ulcers

38 Prevalence Sunny Acres has 100 long stay residents. 25 of those residents are receiving an antipsychotic. 2 residents are schizophrenic and one resident is bipolar. What is the prevalence of antipsychotic use in the facility? What is the incidence?

39 Prevalence 23 residents are on antipsychotics without dx 100 long stay residents.23 X 100 = 23 % Incidence cannot be determined with the information given.

40 Run Charts

41 Control Chart 41 View a process over time Give a visual description of what the process has done and is doing If the process is in control, (random normal variation or random walk), you can predict how the process will perform over time

42 42 Control Chart

43 Process Improvement Projects Performance Improvement Project (PIP) team to address a question  Involve staff working closest to the residents whenever possible  PIP team meets identifies potential root case  Develops action plan/intervention  Monitors and reports back to QAA

44 Root Cause: 5 Whys Why is the resident screaming in her room?  When she is in the dining room she was trying to strike out at other residents Why is she trying to strike out at other residents?  She is fearful that someone is trying to take her food Why is she fearful that someone is trying to take her food?  The doctor cut back on her risperdone dose 2 days ago

45 Root Cause: 5 Whys Why is cutting back on the risperdone dose important?  She is more alert at meals and is afraid that someone is taking her food Why is she afraid someone is taking her food?  She grew up in Germany at the end of world war 2 and Russian soldiers used to come through the village she lived in and steal food


47 facilityresidents Policies and procedures Staff 6 social workers for 362 residents Independent consultant pharmacist No monitoring of which residents are on meds No GDR process Multiple units all function independently Geriatric nurse practitioner and psychiatrist round weekly “Our patients are different” Secured unit for dementia Employed physician model

48 Interventions Meet with attending physicians  Identify barriers to GDR  Monthly review of residents on antipsychotics and GDR Meet with facility psychiatrist and geriatric psych ANP  Require nursing have MD consult request Meet with pharmacy consultant  Request monthly reports regarding psychoactive medication usage

49 Interventions Meet with Director of Nursing  Identify potential barriers  Address staff education opportunities Meet with facility administrator  Identify barriers  Identify potential opportunities Review of current policies and revise as indicated

50 Prevalence of Antipsychotic Use: Jan-Oct 2012

51 Quality Improvement Process Three fundamental questions  What are we trying to accomplish?  Reduce inappropriate medication use  Improve dementia care  How will we know that change is an improvement?  There will be an appropriate reduction in medications  There will not be an increase in incidents  What changes can we make that will result in improvement?

52 The Model for Continuous Improvement - PDCA START Plan Do Check Act

53 QAA Meetings Agenda Reports prepared in advance  Process Improvement Reports  Facility reports Manage the time of the meeting

54 QAPI Resource Library & Tools Web-based Resource Library Content-rich User-friendly Supports diversity of target audiences  Provides  Consumers  Regulators Easy links to tools and resources - relevant to nursing home QAPI

55 National Rollout: Timeline By statute, nursing homes will be expected to have QAPI programs in place that meet a defined standard, one year after CMS issues a QAPI rule. CMS expects to issue a draft regulation for comment in 2012. A final rule is likely to be issued by the end of 2012 or early 2013.


Download ppt "Karyn P. Leible, RN, MD, CMD Chief Medical Officer Jewish Senior Life of Rochester, NY Immediate Past President, AMDA Quality Assurance and Process Improvement."

Similar presentations

Ads by Google